Navigation Links
Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure
Date:2/15/2012

LA JOLLA, Calif., Feb. 15, 2012 /PRNewswire/ -- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced today that it has completed a $43 million equity financing to advance its lead investigational product candidate MYDICAR® for the treatment of heart failure. The financing was led by new investor Pfizer Venture Investments and also included new investors Lundbeckfond Ventures, Novartis Venture Funds, H&Q Healthcare/Life Sciences Investors, and GBS Venture Partners. All previous investors participated in this round including Enterprise Partners Venture Capital, Johnson & Johnson Development Corporation, and Venrock Associates.

In conjunction with this financing, Celladon has added a new slate of directors to its board including Barbara Dalton, Ph.D., of Pfizer Venture Investments (Chair), Johan Kordel, Ph.D., Assoc. Prof., of Lundbeckfond Ventures, Lauren Silverman, Ph.D., of Novartis Venture Funds, Daniel Omstead, Ph.D., of Hambrecht & Quist Capital Management, and Josh Funder, D.Phil., of GBS Venture Partners.  In addition, Andrew Senyei, M.D., of Enterprise Partners Venture Capital will continue to serve as a director.

"We are pleased to have attracted such a top tier syndicate to support advancement of MYDICAR for the benefit of advanced heart failure patients," said Krisztina Zsebo Ph.D., President and CEO of Celladon Corporation. Dr. Zsebo continued, "The positive results of the phase 2 CUPID Trial demonstrated the potential of MYDICAR to become an important treatment for patients with chronic, advanced heart failure."

Celladon Corporation plans to advance the clinical development of MYDICAR in 2012. MYDICAR was recently granted Fast Track Status by the Food and Drug Administration in December, 2011.

"MYDICAR has demonstrated clinical benefit in human clinical trials and we believe that it has the poten
'/>"/>

SOURCE Celladon Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Celladon Corporation Receives FDA Fast Track Designation for Its Investigational Agent MYDICAR® for the Treatment of Heart Failure
2. Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Reduction in Clinical Events in Patients for 18 Months Compared with Placebo
3. Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting
4. Celladon Corporation Announces Presentation of First-in-Human Gene Transfer to Treat Heart Failure at the 12th Annual Meeting of the American Society of Gene Therapy
5. Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions
6. Unilife Corporation Announces Financial Results for Fiscal Year 2012 Second Quarter
7. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
8. Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results
9. Unilife Corporation to Announce Financial Results for Fiscal 2012 Second Quarter on Thursday, February 9, 2012
10. Vystar® Corporation Receives its Third US Patent and First Chinese Patent for Vytex® Natural Rubber Latex
11. Kensey Nash Corporation Announces Its Second Quarter Fiscal Year 2012 Earnings Release Date and Teleconference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Diseases largely eradicated in ... are returning. Measles was declared eliminated in 2000, yet ... of August 15—the highest incidence in 20 years. In ... declared whooping cough a problem of "epidemic proportions." ... and dying from these preventable diseases—in part because some ...
(Date:8/29/2014)... 29, 2014  Abaxis, Inc. (NasdaqGS: ABAX ... and consumables to the medical, research and veterinary markets, ... Chief Executive Officer, will present at the CL King ... Tuesday, September 9, 2014 at 12:30 p.m. ET. The ... Hotel in New York City . ...
(Date:8/29/2014)... -- , Industry professionals and media ... taking place in real-time at CPhI Worldwide  ... UBM Live , announces the launch of #CPhIChat ... its kind global industry-wide Tweetchat for pharma professionals ... to stimulate conversations on key industry issues and ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3
... Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... the three months ended September 30, 2011 (Fiscal Year ... Following the commencement of initial supplies of ... progressively increased production capacities at its York, PA facility. ...
... Calif., Nov. 9, 2011 diaDexus, Inc. (OTC Bulletin Board: ... development and commercialization of patent-protected in vitro diagnostic ... results for the third quarter of 2011. Total ... million, representing 38% growth over total revenues of $3.2 million ...
Cached Medicine Technology:Unilife Corporation Announces Financial Results for Fiscal Year 2012 First Quarter 2Unilife Corporation Announces Financial Results for Fiscal Year 2012 First Quarter 3Unilife Corporation Announces Financial Results for Fiscal Year 2012 First Quarter 4Unilife Corporation Announces Financial Results for Fiscal Year 2012 First Quarter 5Unilife Corporation Announces Financial Results for Fiscal Year 2012 First Quarter 6Unilife Corporation Announces Financial Results for Fiscal Year 2012 First Quarter 7diaDexus, Inc. Reports 38% Year-Over-Year Revenue Growth for 2011 Third Quarter 2diaDexus, Inc. Reports 38% Year-Over-Year Revenue Growth for 2011 Third Quarter 3diaDexus, Inc. Reports 38% Year-Over-Year Revenue Growth for 2011 Third Quarter 4diaDexus, Inc. Reports 38% Year-Over-Year Revenue Growth for 2011 Third Quarter 5diaDexus, Inc. Reports 38% Year-Over-Year Revenue Growth for 2011 Third Quarter 6
(Date:8/31/2014)... 31, 2014 Just in time for Washington’s ... only wild, sustainable Alaska Salmon, award winning chowder ... Duke's Green Lake location , Sunday, September 28, 2014 ... sample several ethnic salmon BBQ culinary delights. Live music will ... from Hawaii, Puerto Rico and Mexico will be featured. ...
(Date:8/31/2014)... Recently, BambooIndustry.com, one of the most popular suppliers of ... of bamboo veneers . Additionally, it has deiced offer ... high quality products. The promotion will last from today until ... its top quality veneers are hot in the global market. ... bamboo veneers. All these items are made according to our ...
(Date:8/31/2014)... Mesa, AZ (PRWEB) August 31, 2014 ... in Mesa, Arizona, prescribes sublingual immunotherapy to help his ... includes tree nut allergies. Dr. Agren said that it ... nut-based foods and, in many cases, restored peace of ... can lead to a host of symptoms, including rashes, ...
(Date:8/31/2014)... With years of hard work, Delta has now ... machines. Recently, the company has updated its wheel loader ... loaders. All these items are guaranteed to be great. Additionally, ... , It is true that all items in Delta’s ... machine specialists. The firm is making full efforts to help ...
(Date:8/31/2014)... (PRWEB) August 31, 2014 1Heart Caregiver ... Clarito and brain fitness expert Tee Barr conducted a ... Ventura City. Activities Director Virginia Ayala and Social Services ... and patients attend this brain fitness session. , Research ... and slowing down the development of dementia and memory ...
Breaking Medicine News(10 mins):Health News:Seattle Seafood Restaurant Duke's Chowder House on Green Lake Will Celebrate The Long Anticipated Indian Summer With First Annual Sizzling BBQ Salmon Tasting Event. 2Health News:High Quality Bamboo Veneers from Bambooindustry.com Receive International Attention 2Health News:Family Allergy Clinic Announces Q4 2014 Release of Oral Drops for Tree Nut Allergies 2Health News:Family Allergy Clinic Announces Q4 2014 Release of Oral Drops for Tree Nut Allergies 3Health News:Delta Updates Its Wheel Loader Assortment With A Lot Of Cheap Used Cat 966 Loaders 2Health News:1Heart Caregiver Services Director Randy Neil Clarito Brings Brain Fitness Education to Victoria Care Center Ventura 2Health News:1Heart Caregiver Services Director Randy Neil Clarito Brings Brain Fitness Education to Victoria Care Center Ventura 3Health News:1Heart Caregiver Services Director Randy Neil Clarito Brings Brain Fitness Education to Victoria Care Center Ventura 4
... Georgia Tech Research Institute (GTRI) have developed a sensor ... to asthma attacks. Worn in the pockets of a ... causes of asthma attacks. , We are investigating whether ... see what was going on environmentally when the attack ...
... The use of regular, long-term aspirin and non-steroidal ... cancer, according to a study published in Gastroenterology ... (AGA) Institute. However, the use of aspirin for chemoprevention ... doses that are higher than recommended over a long ...
... prescription drugs so that the system more closely resembles ... drug use without altering patients out-of-pocket spending, health plan ... RAND Corporation study. , Researchers propose that consumers pay ... a years worth of medicine for each prescription they ...
... need to be monitored closely, study says , , TUESDAY, Jan. ... of patients with kidney or liver cancer also increases the ... Nexavar (sorafenib) need to be carefully monitored and treated, said ... online issue of Lancet Oncology . , Nexavar is ...
... Medicine (IGM) at Johns Hopkins will join other national ... ambitious effort that will involve sequencing the genomes of ... most detailed and medically useful picture to date of ... in creating a map of common DNA variation in ...
... Same-sex couples are just as committed in their ... have studied the quality of adult relationships and ... couples in same-sex relationships are not as committed ... as psychologically healthy. , These results are from ...
Cached Medicine News:Health News:Investigating causes of asthma attacks: New sensor system monitors environmental exposure 2Health News:Regular, long-term aspirin use reduces risk of colorectal cancer 2Health News:Researchers propose consumers buy yearly 'drug licenses' as new way to pay for prescriptions 2Health News:Researchers propose consumers buy yearly 'drug licenses' as new way to pay for prescriptions 3Health News:Liver Cancer Drug Raises Blood Pressure 2Health News:Johns Hopkins to participate in 1000 Genomes Project 2Health News:Equal level of commitment and relationship satisfaction found among gay and heterosexual couples 2Health News:Equal level of commitment and relationship satisfaction found among gay and heterosexual couples 3
... Central Blood Pressure/Pulse Wave Velocity System is an ... system enables the measurement of the velocity of ... The velocity of the pressure wave along the ... artery. This system is most commonly used to ...
Used to remove wrinkles from sections and for reorientating embedded tissue....
Liquichek Blood Gas Plus CO-Oximeter Control (Radiometer) is a combination control for use in monitoring the performance of blood gas, ion-selective electrode, biosensor and CO-Oximeter (Radiometer) ...
Liquichek Blood Gas Plus E Control is an aqueous product used to monitor the measurement of pH, pCO2, pO2 and electrolytes. Available in four levels....
Medicine Products: